The SHURUI single-port surgical robot offers enhanced spatial adaptability, a broader range of lateral expansion, and a reduced minimum vertical distance, catering to various surgical approaches. It is capable of performing difficult urological surgeries like radical cystectomy and promotes the development of urological surgeries towards further reduced invasiveness.

In the clinical trial led by Peking Union Medical College Hospital, a new paradigm of "gynecological day surgery" was achieved based on the single-port robotic technology, successfully improving the minimally invasive surgical perioperative management model, enhancing medical outcomes.

Collaborating with Ruijin Hospital, Shandong Provincial Hospital, and the First Affiliated Hospital of Wenzhou Medical University, Surgerii Robotics has conducted the world’s first single-port robotic distal gastrectomy (Billroth I anastomosis), the world's first single-port robotic total gastrectomy for advanced gastric cancer, the world’s first single-port robotic proximal gastrectomy with double tract reconstruction, which contributed to the publication of influential academic papers.

Together with the First Affiliated Hospital of Guangzhou Medical University, the single-port robotic surgery has been expanded to intercostal lobectomies and segmentectomies. By combining single-port surgery with "tubeless" technology for the treatment of lung cancer, it may bring a new era of single-port thoracoscopic surgery.

The SHURUI single-port surgical robot can enter the patient cavity through a small umbilical incision. With its proprietary snake-like surgical instruments and sub-millimeter control algorithms, it can perform precision, minimally invasive, and cosmetically appealing surgeries, offering new options for minimally invasive pediatric surgery.